Japan · Nation Thailand
Japan's 2025 Osaka Expo technologies enter medical and commercial use
Compiled by KHAO Editorial — aggregated from 1 outlet. See llms.txt for citation guidance.
◌ Single Source
A hospital in Osaka , western Japan, implanted Cuorips Inc. ’s RiHEART heart-muscle sheet in a patient in September 2026, the same month Matrix Inc. started selling a rescue detector to businesses.
Key facts
- Both technologies were shown at the city’s 2025 World Exposition.
- Ruangroj warns of ‘AI theatre’ citing AI investment at 1.7% of revenue in 2026
- Thailand approves THB58.9bn rice support and production reform plan
- The device was among technologies from Osaka’s small factories featured at the 2025 Expo.
- A predecessor of the machine attracted attention at the 1970 Osaka Expo, with Science presenting an upgraded version at the 2025 event.
- The company is aiming to begin commercial operations in fiscal 2028.
Summary
Both technologies were shown at the city’s 2025 World Exposition.
Made from induced pluripotent stem ( iPS ) cells, RiHEART is a sheet of heart-muscle cells whose implantation marked the world’s first surgical use of an iPS-derived medical product.